Evidence map›Paper›PMID 37510195›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Artificial Intelligence-Assisted Processing of Anterior Segment OCT Images in the Diagnosis of Vitreoretinal Lymphoma.

Fabrizio Gozzi, Marco Bertolini, Pietro Gentile, Laura Verzellesi, Valeria Trojani, Luca De Simone, Elena Bolletta, Valentina Mastrofilippo, Enrico Farnetti, Davide Nicoli and 12 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Intraocular Lymphoma: A Review.Journal of ophthalmic & vision research · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Fabrizio GozziOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-4147-5534
Marco BertoliniMedical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0003-3148-1022
Pietro GentileOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Laura VerzellesiMedical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-2615-381X
Valeria TrojaniMedical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-3331-2436
Luca De SimoneOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0003-1471-1914
Elena BollettaOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0003-0292-0153
Valentina MastrofilippoOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Enrico FarnettiMolecular Pathology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Davide NicoliMolecular Pathology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Stefania CrociClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-8622-0439
Lucia BelloniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Alessandro ZerbiniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Chantal AdaniOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-2477-5463
Michele De MariaOphthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Areti KosmarikouOphthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Marco VecchiOphthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Alessandro InvernizziEye Clinic, Luigi Sacco Hospital, Department of Biomedical and Clinical Science, University of Milan, 20157 Milan, Italy.
Fiorella IlariucciHematology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Magda ZanelliSurgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.ORCID 0000-0002-8733-9933
Mauro IoriMedical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-8738-3352
Luca CiminoOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0001-7956-9950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anterior segment optical coherence tomography (AS-OCT) allows the explore not only the anterior chamber but also the front part of the vitreous cavity. Our cross-sectional single-centre study investigated whether AS-OCT can distinguish between vitreous involvement due to vitreoretinal lymphoma (VRL) and vitritis in uveitis. We studied AS-OCT images from 28 patients (11 with biopsy-proven VRL and 17 with differential diagnosis uveitis) using publicly available radiomics software written in MATLAB. Patients were divided into two balanced groups: training and testing. Overall, 3260/3705 (88%) AS-OCT images met our defined quality criteria, making them eligible for analysis. We studied five different sets of grey-level samplings (16, 32, 64, 128, and 256 levels), finding that 128 grey levels performed the best. We selected the five most effective radiomic features ranked by the ability to predict the class (VRL or uveitis). We built a classification model using the xgboost python function; through our model, 87% of eyes were correctly diagnosed as VRL or uveitis, regardless of exam technique or lens status. Areas under the receiver operating characteristic curves (AUC) in the 128 grey-level model were 0.95 [CI 0.94, 0.96] and 0.84 for training and testing datasets, respectively. This preliminary retrospective study highlights how AS-OCT can support ophthalmologists when there is clinical suspicion of VRL.

Indexed as

AIanterior segment optical coherence tomographyartificial intelligenceAS-OCTmachine learningradiomic featuresvitreoretinal lymphomaVRL

Identifiers

PMID37510195
PMCPMC10378347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.